Cathy Schilero
Cleveland Clinic(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Glioma Diagnosis and Treatment, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis
Most-Cited Works
- → Phase II study of Dovitinib in recurrent glioblastoma(2019)43 cited
- → Family History of Cancer in Benign Brain Tumor Subtypes Versus Gliomas(2012)28 cited
- → Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1–3 newly diagnosed brain metastases(2015)27 cited
- → SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update.(2019)17 cited
- → Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer(2014)14 cited
- → Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence.(2020)13 cited
- → ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma(2018)8 cited
- → Prospective Phase I Dose Escalation Study for Neoadjuvant Radiosurgery for Large Brain Metastases(2019)6 cited
- → Phase II trial of dovitinib in recurrent glioblastoma.(2015)6 cited
- → Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma.(2022)6 cited